Kevin G. Lokay

Insider Reports History

Entity
Individual
Location
Glaxosmithkline, Three Franklin Plaza, 1600 Vine Street, Philadelphia, PA
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Kevin G. Lokay
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin G. Lokay:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Galera Therapeutics, Inc. Director Stock Option (Right to Buy) 48K Jun 14, 2023 Direct

Insider Reports Filed by Kevin G. Lokay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRTX Galera Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
GRTX Galera Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director
GRTX Galera Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 17, 2021 Director